Literature DB >> 17081700

Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function.

David Spiegel1, Janine Giese-Davis, C Barr Taylor, Helena Kraemer.   

Abstract

The normal diurnal cortisol cycle has a peak in the morning, decreasing rapidly over the day, with low levels during the night, then rising rapidly again to the morning peak. A pattern of flatter daytime slopes has been associated with more rapid cancer progression in both animals and humans. We studied the relationship between the daytime slopes and other daytime cortisol responses to both pharmacological and psychosocial challenges of hypothalamic-pituitary-adrenal (HPA) axis function as well as DHEA in a sample of 99 women with metastatic breast cancer, in hopes of elucidating the dysregulatory process. We found that the different components of HPA regulation: the daytime cortisol slope, the rise in cortisol from waking to 30 min later, and cortisol response to various challenges, including dexamethasone (DEX) suppression, corticotrophin releasing factor (CRF) activation, and the Trier Social Stress Task, were at best modestly associated. Escape from suppression stimulated by 1mg of DEX administered the night before was moderately but significantly associated with flatter daytime cortisol slopes (r=0.28 to .30 at different times of the post DEX administration day, all p<.01). Daytime cortisol slopes were also moderately but significant associated with the rise in cortisol from waking to 30 min after awakening (r=.29, p=.004, N=96), but not with waking cortisol level (r=-0.13, p=.19). However, we could not detect any association between daytime cortisol slope and activation of cortisol secretion by either CRF infusion or the Trier Social Stress Task. The CRF activation test (following 1.5mg of DEX to assure that the effect was due to exogenous CRF) produced ACTH levels that were correlated (r=0.66, p<.0001, N=74) with serum cortisol levels, indicating adrenal responsiveness to ACTH stimulation. Daytime cortisol slopes were significantly correlated with the slope of DHEA (r=.21, p=.04, N=95). Our general findings suggest that flatter daytime cortisol slopes among metastatic breast cancer patients may be related to disrupted feedback inhibition rather than hypersensitivity in response to stimulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081700      PMCID: PMC1790857          DOI: 10.1016/j.psyneuen.2006.09.004

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  63 in total

Review 1.  Corticotrophin releasing factor in man and its measurement: a review.

Authors:  E A Linton; P J Lowry
Journal:  Clin Endocrinol (Oxf)       Date:  1989-08       Impact factor: 3.478

2.  Plasma cortisol and natural killer cell activity during bereavement.

Authors:  M Irwin; M Daniels; S C Risch; E Bloom; H Weiner
Journal:  Biol Psychiatry       Date:  1988-06       Impact factor: 13.382

3.  White collar work load and cortisol: disruption of a circadian rhythm by job stress?

Authors:  R D Caplan; S Cobb; J R French
Journal:  J Psychosom Res       Date:  1979       Impact factor: 3.006

4.  Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer.

Authors:  G B Gordon; T L Bush; K J Helzlsouer; S R Miller; G W Comstock
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

5.  Different effects of novel stressors on sympathoadrenal system activation in rats exposed to long-term immobilization.

Authors:  Sladjana Dronjak; Daniela Jezova; Richard Kvetnansky
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

6.  Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features.

Authors:  M Kaneko; F Yokoyama; Y Hoshino; K Takahagi; S Murata; M Watanabe; H Kumashiro
Journal:  Neuropsychobiology       Date:  1992       Impact factor: 2.328

7.  Diurnal cortisol rhythm and fatigue in breast cancer survivors.

Authors:  Julienne E Bower; Patricia A Ganz; Sally S Dickerson; Laura Petersen; Najib Aziz; John L Fahey
Journal:  Psychoneuroendocrinology       Date:  2005-01       Impact factor: 4.905

8.  Flattened cortisol rhythms in metastatic breast cancer patients.

Authors:  Heather C Abercrombie; Janine Giese-Davis; Sandra Sephton; Elissa S Epel; Julie M Turner-Cobb; David Spiegel
Journal:  Psychoneuroendocrinology       Date:  2004-09       Impact factor: 4.905

9.  Alterations in morning cortisol associated with PTSD in women with breast cancer.

Authors:  Linda J Luecken; Barbara Dausch; Vanessa Gulla; Richard Hong; Bruce E Compas
Journal:  J Psychosom Res       Date:  2004-01       Impact factor: 3.006

10.  Differences in cortisol awakening response on work days and weekends in women and men from the Whitehall II cohort.

Authors:  Sabine R Kunz-Ebrecht; Clemens Kirschbaum; Michael Marmot; Andrew Steptoe
Journal:  Psychoneuroendocrinology       Date:  2004-05       Impact factor: 4.905

View more
  33 in total

1.  Anti-fatigue effect of Renshen Yangrong decoction in mice.

Authors:  Yan-zhi Chen; Fei Lin; Ping-ping Li
Journal:  Chin J Integr Med       Date:  2011-11-19       Impact factor: 1.978

2.  Diurnal cortisol rhythms, fatigue and psychosocial factors in five-year survivors of ovarian cancer.

Authors:  Michaela G Cuneo; Andrew Schrepf; George M Slavich; Premal H Thaker; Michael Goodheart; David Bender; Steve W Cole; Anil K Sood; Susan K Lutgendorf
Journal:  Psychoneuroendocrinology       Date:  2017-06-30       Impact factor: 4.905

3.  Stress history and breast cancer recurrence.

Authors:  Oxana Palesh; Lisa D Butler; Cheryl Koopman; Janine Giese-Davis; Robert Carlson; David Spiegel
Journal:  J Psychosom Res       Date:  2007-08-02       Impact factor: 3.006

4.  Regional brain activation during verbal declarative memory in metastatic breast cancer.

Authors:  Shelli R Kesler; F Chris Bennett; Misty L Mahaffey; David Spiegel
Journal:  Clin Cancer Res       Date:  2009-10-20       Impact factor: 12.531

5.  Posttraumatic growth and diurnal cortisol slope among women with metastatic breast cancer.

Authors:  Michael Diaz; Arianna Aldridge-Gerry; David Spiegel
Journal:  Psychoneuroendocrinology       Date:  2014-03-12       Impact factor: 4.905

Review 6.  Immune system to brain signaling: neuropsychopharmacological implications.

Authors:  Lucile Capuron; Andrew H Miller
Journal:  Pharmacol Ther       Date:  2011-02-17       Impact factor: 12.310

7.  Adrenal Hormone and Metabolic Biomarker Responses to 30 min of Intermittent Cycling Exercise in Breast Cancer Survivors.

Authors:  E S Evans; A C Hackney; M M Pebole; R G McMurray; H B Muss; A M Deal; C L Battaglini
Journal:  Int J Sports Med       Date:  2016-08-04       Impact factor: 3.118

8.  Qualitative evaluation of care plans for Canadian breast and head-and-neck cancer survivors.

Authors:  K Collie; J McCormick; A Waller; C Railton; L Shirt; J Chobanuk; A Taylor; H Lau; D Hao; B Walley; B Kapusta; A A Joy; L E Carlson; J Giese-Davis
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

9.  A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation.

Authors:  Melissa A Rosenkranz; Richard J Davidson; Donal G Maccoon; John F Sheridan; Ned H Kalin; Antoine Lutz
Journal:  Brain Behav Immun       Date:  2012-10-22       Impact factor: 7.217

10.  Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer.

Authors:  Oxana Palesh; Jamie M Zeitzer; Ansgar Conrad; Janine Giese-Davis; Karen M Mustian; Varinia Popek; Karen Nga; David Spiegel
Journal:  J Clin Sleep Med       Date:  2008-10-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.